hero section gradient
14 handpicked stocks

Made in the UK

Diversify your portfolio with some of Britain's most established companies. Our analysts have carefully selected these UK powerhouses that span multiple industries from banking to pharmaceuticals, energy to consumer goods.

Author avatar

Han Tan | Market Analyst

Published on May 10

Your Basket's Financial Footprint

Market capitalisation breakdown for 'Made in the UK' basket

Key Takeaways for Investors:
  • Large-cap dominance generally means lower volatility and closer tracking of broad market moves, implying relatively lower risk.
  • Use this basket as a core, diversified holding rather than a speculative, short-term growth position.
  • Expect steady, long-term value creation rather than explosive short-term gains; growth tends to be gradual.
Total Market Cap
  • AZN: $258.54B

  • HSBC: $226.47B

  • GSK: $89.36B

  • Other

About This Group of Stocks

1

Our Expert Thinking

The UK represents the world's sixth-largest economy with London as a leading financial hub. These stocks offer a strategic mix of defensive and cyclical investments across diverse sectors like pharmaceuticals, energy, finance, and consumer goods, providing both stability and growth potential.

2

What You Need to Know

This collection features multinational corporations with global presence and influence, underpinned by the UK's strong regulatory framework. Many of these companies offer consistent dividends and represent traditional strength combined with innovative approaches to changing markets.

3

Why These Stocks

These companies were selected for their market leadership, proven resilience, and international reach. From pharmaceutical giant AstraZeneca to energy leaders Shell and BP, these stocks represent Britain's economic strength while offering exposure to various sectors of the global economy.

Why You'll Want to Watch These Stocks

🌍

Global Influence

These UK giants have worldwide reach and operations. Companies like HSBC, Shell, and AstraZeneca are household names globally, letting you tap into international markets through British expertise.

💷

Dividend Powerhouses

Many British companies have long histories of paying consistent dividends. Stocks like British American Tobacco and Diageo are known for rewarding shareholders with regular income alongside potential growth.

🏆

Fortune 500 Prestige

The UK is home to 17 companies on the Fortune Global 500 list. Investing in these market leaders means owning a piece of businesses that shape entire industries and economies worldwide.

Get the full story on this Basket. Read our detailed article on its risks and potential.

Read Full Insight

Why Invest with Nemo Money?

Nemo Logo Fade
🆓

Zero Commission

Trade stocks, ETFs, and more with zero commission. Keep more of your returns.

🔒

Trusted & Regulated

Part of Exinity Group 2015, serving over a million customers globally.

🚀

6% Interest on Cash

Earn 6% AER on uninvested cash with daily interest payments.

Discover More Opportunities

Tech Stocks (AI Valuation Reset) Present Potential Entry

Tech Stocks (AI Valuation Reset) Present Potential Entry

Recent market turmoil, driven by concerns over AI stock valuations, has led to a significant drop in global markets. This correction creates a potential opportunity to invest in fundamentally sound technology companies at more attractive prices.

Walmart Succession Plan Explained | Market Effects

Walmart Succession Plan Explained | Market Effects

Walmart announced a CEO transition, with veteran John Furner taking the helm, which could create opportunities for competitors. This leadership change at a retail giant may cause short-term uncertainty, potentially benefiting other major players in the retail space.

Biotech Buyout Candidates (Post-Merck Acquisition)

Biotech Buyout Candidates (Post-Merck Acquisition)

Merck's $9.2 billion acquisition of Cidara Therapeutics for its antiviral drug pipeline signals a broader industry trend. This creates an investment opportunity in other biotech companies with promising late-stage drugs that could become the next acquisition targets for pharmaceutical giants.

Frequently Asked Questions